Dr. Teitell is a Professor in the Department of Pathology & Laboratory Medicine, in the Department of Pediatrics, and in the Bioengineering Interdepartmental Program at the University of California, Los Angeles. He is the Chief of the Division of Pediatric and Neonatal Pathology, Director of the Cancer Nanotechnology Program in the Jonsson Comprehensive Cancer Center, Director of the NIH Tumor Immunology Training Program, Director of the Broad Stem Cell Research Center Bioengineering Core, a member of the California NanoSystems Institute (CNSI) Executive Steering Committee, and a member of the Medical Scientist Training Program (MSTP) Executive Committee. Dr. Teitell was elected to the American Society of Clinical Investigators and was a Leukemia and Lymphoma Society Stohlman Scholar. His research lab studies the function of human pluripotent stem cells through the collaborative generation of novel investigative nanotools, including a photothermal nanoblade and a live cell interferometer. Recent studies of embryonic stem cell mitochondrial metabolism have shown parallel changes with cancer cells, suggesting a common mechanism for energy generation and a potential new therapeutic angle. His lab was the first to generate a genetic small animal model for the major types of immune system malignancies that occur in humans that is used by laboratories worldwide. He also collaboratively developed new nanoscale methods for quantifying cell responses to environmental perturbations, both internal and external, in real-time as a new approach for quantifying cellular behavior and responses one cell at a time within a population.
